Sichuan Hebang Biotechnology (603077.SH) issued a profit warning, expecting a 96.88% to 97.66% year-on-year decline in net profit for the fiscal year 2024.
Habio (603077.SH) announces a decrease in performance forecast for the year 2024, expecting a decrease in net profit...
Sichuan Hebang Biotechnology (603077.SH) announced a forecasted decrease in performance for the year 2024, estimating a net profit attributable to shareholders of the listed company of 30 to 40 million yuan, a year-on-year decrease of 96.88% to 97.66%.
Related Articles
Feihe's Lovebook wins international scientific research award! Deciphering the nutritional pain points of the elderly, the results are implemented to empower product upgrades.
The AI trend has pushed up demand for storage chips. Samsung Electronics' semiconductor department saw profits in Q3 soar by 79%, greatly exceeding expectations.
New stock news | Intending to list "A+H" Guangdong Dtech Technology (301377.SZ) announced its IPO in Hong Kong.
Feihe's Lovebook wins international scientific research award! Deciphering the nutritional pain points of the elderly, the results are implemented to empower product upgrades.
The AI trend has pushed up demand for storage chips. Samsung Electronics' semiconductor department saw profits in Q3 soar by 79%, greatly exceeding expectations.
New stock news | Intending to list "A+H" Guangdong Dtech Technology (301377.SZ) announced its IPO in Hong Kong.
RECOMMEND
The Capital Conundrum of Dongpeng Beverage: Distributing ¥5.4 Billion in Profits While Raising Capital in Hong Kong with Over ¥10 Billion Cash on Hand | IPO Watch
29/10/2025
Totaling $550 Billion: Japan’s U.S. Investment Project List Revealed, Largest Projects Near $100 Billion, U.S. Stocks in Related Sectors Rally
29/10/2025
Humanoid Robot Theme Maintains Momentum — Cathie Wood Backs It as One of AI’s Largest Opportunities
29/10/2025
